Literature DB >> 3064712

Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.

G Papamichalis1, K Francia, F E Karachaliou, O T Anastasiades, D A Spandidos.   

Abstract

Sections derived from fibrocystic disease in human breast tissue were examined for the presence of the c-myc oncoprotein by using the c-myc specific monoclonal antibody 9E10 (1). The results obtained revealed that the c-myc gene was not expressed in normal epithelial cells either of ducts or lobules. It was expressed mainly in mucous metaplastic cells and very rarely in apocrine cells. The c-myc protein was observed at a higher level in mucous metaplastic cells of epitheliosis and multiple papillomas. The number and intensity of positive mucous metaplastic cells was significantly increased after pretreating the sections with neuraminidase. We suggest that elevated expression of the c-myc nuclear oncoprotein in human breast metaplastic epithelial cells play a role in the early stages of malignant cell transformation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064712

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  The enigmatic nature of apocrine breast lesions.

Authors:  P Zagorianakou; N Zagorianakou; D Stefanou; G Makrydimas; N J Agnantis
Journal:  Virchows Arch       Date:  2006-03-29       Impact factor: 4.064

2.  Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Authors:  Julio E Celis; José M A Moreira; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans; Fritz Rank
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

3.  Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast.

Authors:  Z P Pavelic; K Pavelic; C P Carter; L Pavelic
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression.

Authors:  Ho Kyung Seo; Seung-Phil Shin; Na-Rae Jung; Whi-An Kwon; Kyung-Chae Jeong; Sang-Jin Lee
Journal:  Oncotarget       Date:  2016-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.